Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]

Han MK. Int J Chron Obstruct Pulmon Dis. 2020;15: 711–721 Page 718, Disclosure section, the disclosure statement was incomplete, the correct statement is “MeiLan K Han reports consulting fees from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Merck, Mylan and Novartis. She...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Han MK
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/3396059b3ca24ddaac9616940254d02c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3396059b3ca24ddaac9616940254d02c
record_format dspace
spelling oai:doaj.org-article:3396059b3ca24ddaac9616940254d02c2021-11-04T19:00:26ZChronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]1178-2005https://doaj.org/article/3396059b3ca24ddaac9616940254d02c2021-11-01T00:00:00Zhttps://www.dovepress.com/corrigendum-chronic-obstructive-pulmonary-disease-in-women-a-biologica-peer-reviewed-fulltext-article-COPDhttps://doaj.org/toc/1178-2005Han MK. Int J Chron Obstruct Pulmon Dis. 2020;15: 711–721 Page 718, Disclosure section, the disclosure statement was incomplete, the correct statement is “MeiLan K Han reports consulting fees from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Merck, Mylan and Novartis. She also reports research support from Novartis and Sunovion. Boehringer Ingelheim also supported conduction of the systematic search. The author reports no other conflicts of interest in this work.” The author apologizes for this error. Read the original articleHan MKDove Medical PressarticleDiseases of the respiratory systemRC705-779ENInternational Journal of COPD, Vol Volume 16, Pp 3017-3018 (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the respiratory system
RC705-779
spellingShingle Diseases of the respiratory system
RC705-779
Han MK
Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]
description Han MK. Int J Chron Obstruct Pulmon Dis. 2020;15: 711–721 Page 718, Disclosure section, the disclosure statement was incomplete, the correct statement is “MeiLan K Han reports consulting fees from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Merck, Mylan and Novartis. She also reports research support from Novartis and Sunovion. Boehringer Ingelheim also supported conduction of the systematic search. The author reports no other conflicts of interest in this work.” The author apologizes for this error. Read the original article
format article
author Han MK
author_facet Han MK
author_sort Han MK
title Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]
title_short Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]
title_full Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]
title_fullStr Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]
title_full_unstemmed Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]
title_sort chronic obstructive pulmonary disease in women: a biologically focused review with a systematic search strategy [corrigendum]
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/3396059b3ca24ddaac9616940254d02c
work_keys_str_mv AT hanmk chronicobstructivepulmonarydiseaseinwomenabiologicallyfocusedreviewwithasystematicsearchstrategycorrigendum
_version_ 1718444640001064960